Bibliografia
American cancer Society. Cancer facts and figures 2006. Atlanta, GA: American Cancer Society, 2006.
Ates NA, Tamer L, Ates C, Ercan B, Elipek T, Ocal K, Camdeviren H. Glutathione S- Transferase M1, T1, P1 Genotypes and Risk for Development of Colorectal cancer.
Biochenical genetics 2005; 43: 149-163.
Bingham SA, Hughes R, Cross AJ. Effect of white versus red meat on endogenous N- nitrosation in the human colon and further evidence of a dose responce. J Nutr 2002;
132 (11 suppl): 3522S-5S.
Broderick P, Carvajal-Carmona L, Pittman AM, Webb E, Howarth K et a. A genome wide association study shows that common alleles of SMAD7 influence colorectal cancer risk. Nature Genetics 2007; 39 (11): 1315-17.
Brownwer WS, Newman TB. Are all significant P values created equal? The analogy between diagnostic tests and clinical research. JAMA 1987; 257: 2459-63.
Buonarati MH, Turteltaub KW, Shen NH, Felton JS. Role of sulfation and acetylation in the activation of 2-hydroxiamino-1- methyl-6-phenylimidazo[4,5-b]pyridine to
intermediates which bind DNA. Mutat Res 1990; 245: 185-190.
Butler LM, Duguay Y, Millikan C, Sinha R, Gagnè JF, Sandler RS, Guillemette C. Joint effects between UDP-Glucuronosyltransferase 1A7 genotype and dietary carcinogen exposure on risk of colon cancer. Cancer Epidemiol Biomarkers Prev 2005; 14 (7):
1626- 1632.
Butler LM, Millikan RC, Sinha R, Keku TO, Winkel S, Harlan B, Eaton A, Gammon MD, Sandler RS. Modification by N-acetyltransferase 1 genotype on the association
between dietary heterocyclic amines and colon cancer in a multiethnic study. Mutat.
Res. 2008; 638: 162-174.
Butler WJ, Ryan P, Roberts-Thomson IC. Metabolic genotypes and risk for colorectal cancer. Journal of Gastroenterology and hepatology 2001; 16: 631-635.
Butterworth AS, Higgins JPT, Pharoah P. Relative and absolute risk of colorectal cancer for individuals with a family history: A meta-analysis. European Journal of cancer 2006; 42: 216-227.
Chen K, Jin M, Zhu Y, Jiang Q, Yu W, Ma X, Yao K. Genetic polymorphisms of uridine diphosphate glucuronosyltransferase 1A7 and colorectal cancer risk in relation to cigarette smoking and alcohol drinking in a Chinese population. Journal of Gastroenterology and Hepatology. 2006; 21:1036-1041.
Coles B, Nowell SA, MacLeod SL, Sweeny C, Lang NP, Kadlubar FF. The role of human glutathione S-transferases (hGSTs) in the detoxification of the food-derived carcinogenmetabolite N-acetoxy-PhIP, and the effect of a polymorphism in hGSTA1 on colorectal cancer risk. Mutat Res 2001; 482: 3-10.
Colhoun H.M., Mckeigue P.M., Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet 2003; 361: 865-72.
Collet JP, Sharpe C, Belzile E, Boivin JF, Hanley J, Abenhaim L. Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing. Br J Cancer 1999. 81: 62-68.
De Jong MM, Nolte IM, Te Meerman GJ, Van der Graaf WTA, De Vries EGE, Sijmons RH, Hofstra RMW, Kleibeuker JH. Low-pennetrance genes and their involvement in colorectal cancer susceptibility. Cancer Epidemiology, Biomarkers e Prevention 2002;
11: 1332-1352.
Dutton GJ. Glucuronidation of drugs and other compounds. Boca Raton, FL: CRC press,1980.
Eisenbrand G, Tang W. Food-borne heterocyclic amines. Chemestry, formation, occurrence and biological activities. A literature review, toxicology 1993, 84:1-82.
Fairley T.L., Cardinez C. J., Martin J., Alley L., Friedman C., Edwards B., Jamison P.
Colorectal cancerin U.S adults younger than 50 years of age, 1998-2001 Cancer 2006, 107 (5 suppl): 1153-61.
Feinberg AP, Tycko B. The history of cancer epigenetics. Nat Rev Cancer 2004; 4:
143-153.
Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P. The effect of novel polymorphisms in interleukin-6 (IL6) gene on IL6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Investig 1998; 102: 1369-1376.
Fretland AJ, Leff MA, Doll MA, Hein DW. Functional characterization of human N- acetyltransferase 2 (NAT2) single nucleotide polymorphisms. Pharmacogenetics 2001;
11: 207-215.
Freudenheim Jo L., Graham S., Horvath P.J et al. Risks associated with source of fiber and fiber components in cancer of the colon and the rectum. Cancer research 1990;
50: 3295- 3300.
Garcia-Closas M, Wacholder S., Caporaso N. Et al. Inference issues in cohort and case-control studies of genetic effects and gene-environment interaction. In: Khoury MJ, Little J, Burke W, editors. Human genome epidemiology: a scientific foundation for using genetic information to improve health and prevent disease. New York (NY);
Oxford University Press; 2004, p.127-44.
Garrity-Park MM, Loftus EVJr, Bryant SC, Sandborn WJ, Smyrk TC. Tumor necrosis factor-alpha polymorphisms in ulcerative colitis-associated colorectal cancer. Am J Gastroenterol 2008; 103 (2): 407-415.
Giovannucci E., Wu K., Cancers of the colum and rectum. In Schottenfeld D., Fraumeni JF editors. Cancer epidemiology and prevention. 3rd edition new York: Oxford; 2006. p.
809-29.
Gong QH, Cho JW, Huang T et al. Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics 2001; 11: 357- 368.
Goodman SN. Toward evidence –based medical statistic. 2: The Bayes factor. Ann.
Intern. Med. 1999; 130 (12): 1005-13.
Guengerich FP, McCormick WA, Wheeler JB. Analysis of the kinetic mechanism of haloalkane conjugation by mammalian Theta-class glutathione transferases. Chem.
Res. Toxicol. 2003; 16: 1493-99.
Hamada K, Unemoto A, Kajikawa A, et al. In vitro formation of DNA adducts with bile acids. Carcinogenesis 1994; 15: 1911-1915.
Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu. Rev. Pharmocol.
Toxicol. 2005; 45: 51-88.
Hein DW, Doll MA, Fretland AJ, Leff MA, Webb SJ, Xiao GH, Devanaboyina US, Nangju NA, Feng Y. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol. Biomarkers prev. 2000; Prev.9: 29-42.
Hein DW. Molecular genetics and function of NAT1 and NAT2 : role in aromatic amine metabolism and carcinogenesis. Mutat Res 2002; 506/507: 65-77.
IARC IARC Monographs on the evaluation of carcinogenic risks to humans, vol. 38, Tobacco smoking, IARC , Lyon,1986.
Ioannidis J. P.Why most published research finding are false. PloS Med 2005. 2(8):
124.
Jemal A., Siegel R., Ward E., Murray T., Xu J., Thun M.J. Cancer statistic,2007. CA Cancer j Clin. 2007; 57: 43-66.
Ji W, Hernandez R, Zhang XY, Qu GZ, Frady A, Varela M, Ehrlich M. DNA demethylation and pericentromeric rearrangements of chromosome 1. Mutat Res 1997; 379: 33-41.
Kaiser S, Park YK, Franklin JL, Halberg RB, Yu M et al. Transcriptional recapitulation and subversion of embryoic colon development by mouse colon tumor models and human colon cancer. Genome Biology 2007; 8: R131.
Kinzler KW, Vogelstein B. Landscaping the cancer terram. Science 1998; 280: 1036- 37.
Klersy C. I test multipli. G Ital Aritmol Cardiostim 2001; 4: 145-48.
Kuppuswamy MN, Hoffmann JW, Kasper CK, Spitzer SG, Groce SL, Bajaj SP. Single nucleotide primer extension to detect genetic diseases: experimental application to hemophilia B (factor IX) and cystic fibrosis genes. Proc Natl Acad Sci U S A. 1991; 88:
1143-1147.
Kurg A, Tonisson N, Geogiou I, Shumaker J, Tollett J, Metspalu A. Arrayed Primer Extension: solid –Phase Four-color DNA Resequencing and Mutation Dataction Technology. Genetic Testing 2000; 4 (1): 1-6.
Landi S, Gemignani F, Moreno V, Gioia-Patricola L, Chabrier A, Guino E, Navarro M, De Oca J, Capella G, Canzian F and for the Bellvitge Colorectal Cancer Study Group.
A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer. Pharmacogenetics and Genomics 2005; 15 (8): 535-546.
Landi S, Moreno V, Gioia-Patricola L, Guino E, Navarro M, De Oca J, Capella G, Canzian F for the Bellvitge Colorectal Cancer Study Group. Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, Tumor Necrosis Factor α, NFKB1, and Peroxisome Proliferator-activated Receptor γ with colorectal cancer.
Cancer research 2003; 63: 3560-3566.
Lang NP, Chu DZ, Hunter CF, Kendall DC, Flammang TJ, Kadlubar FF. Role of aromatic amine acetyltransferase in human colorectal cancer. Arch. Surg. 1986; 121:
1259-1261.
Langouet S, Paehler A, Welti DH, Kerriguy N, Guillouzo A, Touresky RJ. Differential metabolism of 2-amino-1–methyl-6-phenylimidazo[4,5-b]pyridine in rat and human hepatocytes. Carcinogenesis 2002; 23:115-122.
Layton DW, Bogen KT, Knize MG, Hatch FT, Johnson VM, Felton JS. Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research.
Carcinogenesis 1995; 16: 39-52.
Le Blanc GA, Waxman DJ. Interaction of anticancer drugs with hepatic monooxygenasi enzymes. Drug Metab Rev 1989; 20: 395-439.
Lijinsky W, Shubik P. Benzo(a)pyrene and other polynuclear hydrocarbons in charcoal- broiled meat. Science 1964; 145: 53-55.
Lijinsky W, The formation and occurrence of polynuclear aromatic hydrocarbons associated with food. Mutat Res 1991; 259: 251-261.
Liu W, Chang B, Cramer S, Koty PP, Li T, Sun J, Turner AR, Kap-Herr CV, Bobby P, Rao J, Zheng SL, Isaacs WB, Xu J. Deletion of a Small Consensus Region at 6q15, including the MAP3K7 gene, is significantly associated with high-grade prostate cancers. Clin Cancer Res 2007; 13 (17): 5028- 5033.
Malfatti MA, Felton JS, N-Glucuronidation of 2-amino-1–methyl-6-phenylimidazo[4,5- b]pyridine (PhIP) and N-hydroxy-PhIP by specific human UDP-
glucuronosyltransferases, Carcinogenesis 2001; 22: 1087.
Marnett LJ. Aspirin and the potential role of prostaglandins in colorectal cancer. Cancer Research 1992; 52: 5575-5589.
Martinez M. E., Heddens H., Earnest DL, Bogert CL, Roe D, Einspahr J, Marshall JR, Alberts S. Physical activity, body mass index, and prostaglandin E2 levels in rectal Mucosa. Journal of the National Cancer Institute 1999. Vol. 91, No 11: 950-953.
Nagengast FM, Grubben MJ, Van Munster IP. Role of bile acids in colorectal carcinogenesis. Eur J Cancer 1995; 31A: 1067-1070.
Norat T., Bingham S., Ferrari P. et al. Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition. J Nat Cancer Inst. 2005;
97( 12):906-916.
Nusrat A, Sitaraman SV, Neish A. Interaction of bacterial toxins with intestinal epithelial cells. Curr Gastroenterol Rep 2001; 3: 392-398.
Peters AHFM, Mermoud JE, O’Caroll D, Pagani M, Schweizer D, Brockdorff N, Jenuwein T. Histone H3 lysine 9 methylation is an epigenetic imprint of facultative heterochromatin. Nat Genet 2002; 30: 77-80.
Petrlow TP, Barrow BJ, Ashton WS, et al. Aberrant crypts: putative preneoplastic foci in human colonic mucosa. CANCER Res. 1991; 511: 564-67.
Pharoah P.D.P., Dunning A.M., Ponder B.A.J. et al. Association studies for finding cancer-susceptibility genetic variants. Nat. Rev. cancer 2004; 4(11):850-860.
Powis G, Prough RA, eds. Metabolism and action of anticancer drugs. London: Taylor and Francis, 1987.
Qu GZ, Grundy PE, Narayan A, Ehrlich M. Frequent hypometylation in Wilms tumors of pericentromeric DNA in chromosomes 1 and 16. Cancer Genet Cytogenet 1999; 109:
34-39.
Roberts-Thomson IC, Ryan P, Khoo KK, Hart WJ, McMichael AJ, Butler RN. Diet, acetylator phenotype and risk of colorectal neoplasia. Lancet 1996; 347: 1372-1374.
Saadat I, Saadat M. Glutathione S-transferase M1 and T1 null genotypes and the risk of gastrica and colorectal cancer. Cancer letters 2001; 169: 21-26.
Sachse C, Smith G, Wilkie MJV, Barrett JH, Waxman R, Sullivan F, Forman D, Bishop DT, Wolfl CR. The Colon Cancer Study Group. A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcinogenesis 2003; 23 (11): 1839-1849.
Shipkova M, Strassburg CP, Braun F, Streit F, Grone HJ, Armstrong VW, Tukey RH, Oellerich M, Wieland E. Glucuronide and glucoside conjugation of mycophenolic acid by human liver, kidney and intestinal microsomes. Br J Pharmacol 2001; 132: 1027- 1034.
Slattery ML, Wolff RK, Herrick JS, Caan BJ, Potter JD. IL6 genotypes and colon and rectal cancer. Cancer Causes Control 2007; 18: 1095-1105.
Smalley W, Ray WA, Daugherty I, Griffin MR. Use of nonsteroidal anti- innflammatory drugs and incidence of colorectal cancer: a population-based study. Arch Intern Med 1999; 159: 161-166.
Sokolov BP. Primer extension technique for the detection of single nucleotide in
Sterne J.A.; Davey Smith G. Sifting the evidence –what’s wrong with significance test?
BMJ 2001; 322: 226-31.
Strange RC, Spiteri MA, Ramachandran S, Fryer AA. Glutathione-S-transferase family of enzymes. Mutat. Res. 2001; 482: 21-26.
Strassburg CP, Manns MP, Tukey RH. Expression of the UDP-glucuronosultransferase 1A locus in human colon. J Biol Chem 1998; 273: 8719-26.
Strassburg CP, Oldhafer K, Manns MP, Turkey RH. Differential expression of the UGT1A locus in human liver, biliary,and gastric tissue: identification of UGT1A7 and UGT1A10 transcripts in extrahepatic tissue. Mol Pharmacol 1997; 52: 212-20.
Strassburg CP, Vogel A, Kneip S, Tukey RH, Manns MP. Polymorphisms of the human UDP-Glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer. Gut 2002; 50:
851-856.
Strate LL, Syngal S. Hereditary colorectal cancer syndromes. Cancer causes and control 2005; 16: 201-213.
Stryer L. Biochimica edizione Zanichelli pag 822-823.
Sugimura T. Nutrition and dietary carcinogens. Carcinogenesis 2000; 21: 387-395.
Sykora J, Subrt I, Dedek P, Siala K, Schwarz J, Machalova V, Varvarovska J, Pazdiora P, Pozler O, Stozicky F. Cytokine Tumor Necrosis Factor-alpha A promoter gene polymorphism at position -308 G→A and Pediatric Infiammatory Bowel Disease:
implications in ulcerative colitis and Chron’s disease. Journal of Pediatric Gastroenterology and Nutrition 2006; 42: 479-487.
Syvanen AC, Aalto-Setala K, Harju L, Kontula K, Soderlund H. A primer-guided
nucleotide incorporation assay in the genotyping of apolipoprotein E. Genomics. 1990;
8: 684-692.
Tenesa A, Farrington SM, Predergast JGD, Porteous ME, Walker M, Haq N, Barnetson RA et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 amnd 18q21. Nature Genetics 2008 .
Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 2000; 275:18138-18144.
Thomas D.C., Witte J.S. Point: popular stratification : a problem for case control studies of candidate gene association? Cancer Epidemiol. Biomarkers Prev. 2002; 11:
505-12.
Tomlinson I, Webb E, Carvajal-Carmon L, Broderick P, Kemp Z, Spain S, Penegar S et al. A genome widw association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nature Genetics 2007; 39 (8):984-88.ù
Tomlinson IPM, Webb E, Carvajal-Carmon L, Broderick P, Howarth K, Pittman AM, Spain S.et al. a genome-wide association study identifies colorectal cancer
susceptibility loci on chromosomes 10p14 and 8q23.3. Nature Genetics 2008.
Tukey RH, Strassburg CP. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol 2000; 40:581-616.
Van der Logt EMJ, Bergevoet SM, Roelofs HMJ, Van Hooijdonk, Te Morsche RHM, Wobbes T, De Kok JB, Nagengast FM, Peters WHM. Genetic polymorphisms in UDP- glucuronosyltransferases and glutathione S-transferases and colorectal cancer risk.
Carcinogenesis 2004; 25: 2407-2415.
Vickers MA, Green FR, Terry C, Mayosi BM, Julier C, Lathrop M, Ratcliffe PJ, Watkins HC, Keavney B. Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C –reactive protein. Cardovasc Res 2002;
52: 1029-1034.
Vlahcevic ZR, Heuman DM, Hylemon PB. Physiology and pathophysiology of
enterohepatic circulation of bile acids, In ZakimD, Boyer T, eds. Hepatology: A textbook of liver disease; 3rd ed, vol.1. Philadelphia: Saunders, 1996:376-417.
Vogelstein B, Fearon ER, Hamilton SR, et al. genetic alterations during colorectal- tumor development. N Engl J Med. 1988; 319:525-32.
Wacholder S., Chanock S., Garcia-Closas M. et al. Assessing the probability that a positive report is false: An approach for molecular epidemiology studies. J. Natl.
Cancer Inst. 2004; 96(6) , 434-442.
Wacholder S., Rothman N., Caporaso N. Counterpoint: bias from population
stratification is not a major threat to the validity of conclusions from epidemiological studies of common polymorphisms and cancer. Cancer Epidemiol. Biomarkers Prev.
2002; 11: 513-20.
Wheeler JB, Stourman NV, Their R, Dommermuth A, Vuilleumier S et al. Conjugation of haloalkanes by bacterial and mammalian glutathione transferases: mono and- dihalomethanes. Chem. Res. Toxicol. 2001; 14: 1118-27.
Zanke BW, Greenwood CMT, Rangrej J, Kustra R, Tenesa A, Farrington SM, Prendergast J et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nature Genetics 2007; 39 (8): 989-94.
